Caspofungin (Alchemy) New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

caspofungin (alchemy)

alchemy health limited - caspofungin acetate 55.52mg equivalent to caspofungin 50mg;   - powder for infusion concentrate - 50 mg - active: caspofungin acetate 55.52mg equivalent to caspofungin 50mg   excipient: glacial acetic acid mannitol sodium hydroxide sucrose - caspofungin is indicated for: · empirical therapy for presumed fungal infections in febrile, neutropaenic patients ·treatment of invasive candidiasis, including candidaemia, in neutropaenic and non-neutropaenic patients ·treatment of oesophageal candidiasis · treatment of oropharyngeal candidiasis ·treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Caspofungin (Alchemy) New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

caspofungin (alchemy)

alchemy health limited - caspofungin acetate 77.69mg equivalent to caspofungin 70mg;   - powder for infusion concentrate - 70 mg - active: caspofungin acetate 77.69mg equivalent to caspofungin 70mg   excipient: glacial acetic acid mannitol sodium hydroxide sucrose - caspofungin is indicated for: · empirical therapy for presumed fungal infections in febrile, neutropaenic patients ·treatment of invasive candidiasis, including candidaemia, in neutropaenic and non-neutropaenic patients ·treatment of oesophageal candidiasis · treatment of oropharyngeal candidiasis ·treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

CANCIDAS- caspofungin acetate injection, powder, lyophilized, for solution Stati Uniti - Ingliż - NLM (National Library of Medicine)

cancidas- caspofungin acetate injection, powder, lyophilized, for solution

merck sharp & dohme llc - caspofungin acetate (unii: vuw370o5qe) (caspofungin - unii:f0xdi6zl63) - caspofungin acetate 5 mg in 1 ml - cancidas® is indicated as empirical therapy for presumed fungal infections in febrile, neutropenic adult and pediatric patients (3 months of age and older) [see clinical studies (14.1, 14.5)]. cancidas is indicated for the treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis, and pleural space infections in adult and pediatric patients (3 months of age and older) [see clinical studies (14.2, 14.5)]. limitations of use: cancidas has not been studied in endocarditis, osteomyelitis, and meningitis due to candida . cancidas is indicated for the treatment of esophageal candidiasis in adult and pediatric patients (3 months of age and older) [see clinical studies (14.3, 14.5)]. limitations of use: cancidas has not been approved for the treatment of oropharyngeal candidiasis (opc). in the study that evaluated the efficacy of caspofungin in the treatment of esophageal candidiasis, patients with concomitant opc had higher relapse rate of the opc [see clinical studies

CASPOFUNGIN JUNO caspofungin (as acetate) 50mg powder for injection vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

caspofungin juno caspofungin (as acetate) 50mg powder for injection vial

medtas pty ltd - caspofungin acetate, quantity: 55.5 mg - injection, powder for - excipient ingredients: mannitol; sucrose; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - canspofungin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

CASPOFUNGIN JUNO caspofungin (as acetate) 70mg powder for injection vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

caspofungin juno caspofungin (as acetate) 70mg powder for injection vial

medtas pty ltd - caspofungin acetate, quantity: 77.7 mg - injection, powder for - excipient ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - canspofungin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

CASPOFUNGIN ACETATE FOR INJECTION POWDER FOR SOLUTION Kanada - Ingliż - Health Canada

caspofungin acetate for injection powder for solution

sandoz canada incorporated - caspofungin (caspofungin acetate) - powder for solution - 50mg - caspofungin (caspofungin acetate) 50mg - echinocandins

CASPOFUNGIN ACETATE FOR INJECTION POWDER FOR SOLUTION Kanada - Ingliż - Health Canada

caspofungin acetate for injection powder for solution

sandoz canada incorporated - caspofungin (caspofungin acetate) - powder for solution - 70mg - caspofungin (caspofungin acetate) 70mg - echinocandins

CASPOFUNGIN FOR INJECTION POWDER FOR SOLUTION Kanada - Ingliż - Health Canada

caspofungin for injection powder for solution

juno pharmaceuticals corp. - caspofungin (caspofungin acetate) - powder for solution - 50mg - caspofungin (caspofungin acetate) 50mg - echinocandins

CASPOFUNGIN FOR INJECTION POWDER FOR SOLUTION Kanada - Ingliż - Health Canada

caspofungin for injection powder for solution

juno pharmaceuticals corp. - caspofungin (caspofungin acetate) - powder for solution - 70mg - caspofungin (caspofungin acetate) 70mg - echinocandins

CASPOFUNGIN FOR INJECTION POWDER FOR SOLUTION Kanada - Ingliż - Health Canada

caspofungin for injection powder for solution

fresenius kabi canada ltd - caspofungin (caspofungin acetate) - powder for solution - 50mg - caspofungin (caspofungin acetate) 50mg - echinocandins